Construction of recombinant adeno-associated virus expressing apoptin and anti-tumor effect on humn bladder cancerin vitro
Chunhui Wang, Jiansong Wang, Li-rui Yu, Hui Zhan, Hong-yi Xu
Abstract
Chunhui Wang, Jiansong Wang, Li-rui Yu, Hui Zhan, Hong-yi Xu
Abstract
Objective To construct the recombinant adeno-associated virus (AAV) expressing apoptin and investigate the anti-tumor capabilities of AAV-mediated expression of VP3 to human bladder cancer cells in vitro.Methods In this study the AAV Helper-Free System was used to generate the recombinant adeno-associated virus expressing VP3 gene.The VP3 gene was cloned into the expression vector pAAV-MCS and the recombinant plasmid pAAV-VP3 was confirmed by double enzymatic digestion using EcoR Ⅰ and Sal Ⅰ.The recombinant expression plasmid was co-transfected into the AAV-293 cells with pHelper and pAAV-RC to produce recombinant AAV viral particles.The morphological features of the virus particles were examined under the electron microscopy.The physical titer of recombinant AAV was measured through digoxigenin-labeled CMV probe dot blot method,and the recombinant virus was verified by polymerase chain reaction (PCR) of the exogenous interest genes of apoptin.EJ cells were infected by recombinant virus with 5 × 105 vector genomes per cell.Reverse transcription ( RT)-PCR and Western blotting were performed to detect the transcription and expression of apoptin.Concerning on the anti-tumor activity in vitro,transmission electron microscopy was used to determine the apoptotic morphological changes of EJ cells after rAAV-VP3 infection.The cell cycle and apoptosis of EJ cells were quantified by using flow cytometry at 4th day after infection of rAAV-VP3.Results The expression vector pAAV-VP3 was successfully constructed and the sequence of the VP3 was confirmed by DNA sequencing.The rAAV-VP3 was obtained by three plasmids cotransfection into AAV-293 cells after 72 h.The recombinant adeno-associated virus had a high titer of 5.1 × 1011 v.g./ml,and virus particles could be observed under the electron microscopy.After infection of EJ cells with rAAV-VP3,the transcription and expression of VP3 gene were detected by RT-PCR and Western blotting.The rAAV-VP3-induced morphological changes of apoptosis such as fragmentation and apoptotic body were observed under the transmission electron microcopy.Moreover,the proliferation of EJ cells was slowed down,and the proportion of cells at S phase was decreased and that at G2/M phase was blocked after rAAV-VP3 infection as compared with control group (P <0.01 ).Conclusion AAV-mediated VP3 gene transfer may be a new therapeutic technique for the treatment of bladder neoplasms,which may lay a foundation for further studies on anti-tumor effect of bladder cancer in vivo. Key words: VP3 protein; Bladder neoplasm; Gene therapy
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To construct the recombinant adeno-associated virus (AAV) expressing apoptin and investigate the anti-tumor capabilities of AAV-mediated expression of VP3 to human bladder cancer cells in vitro.Methods In this study the AAV Helper-Free System was used to generate the recombinant adeno-associated virus expressing VP3 gene.The VP3 gene was cloned into the expression vector pAAV-MCS and the recombinant plasmid pAAV-VP3 was confirmed by double enzymatic digestion using EcoR Ⅰ and Sal Ⅰ.The recombinant expression plasmid was co-transfected into the AAV-293 cells with pHelper and pAAV-RC to produce recombinant AAV viral particles.The morphological features of the virus particles were examined under the electron microscopy.The physical titer of recombinant AAV was measured through digoxigenin-labeled CMV probe dot blot method,and the recombinant virus was verified by polymerase chain reaction (PCR) of the exogenous interest genes of apoptin.EJ cells were infected by recombinant virus with 5 × 105 vector genomes per cell.Reverse transcription ( RT)-PCR and Western blotting were performed to detect the transcription and expression of apoptin.Concerning on the anti-tumor activity in vitro,transmission electron microscopy was used to determine the apoptotic morphological changes of EJ cells after rAAV-VP3 infection.The cell cycle and apoptosis of EJ cells were quantified by using flow cytometry at 4th day after infection of rAAV-VP3.Results The expression vector pAAV-VP3 was successfully constructed and the sequence of the VP3 was confirmed by DNA sequencing.The rAAV-VP3 was obtained by three plasmids cotransfection into AAV-293 cells after 72 h.The recombinant adeno-associated virus had a high titer of 5.1 × 1011 v.g./ml,and virus particles could be observed under the electron microscopy.After infection of EJ cells with rAAV-VP3,the transcription and expression of VP3 gene were detected by RT-PCR and Western blotting.The rAAV-VP3-induced morphological changes of apoptosis such as fragmentation and apoptotic body were observed under the transmission electron microcopy.Moreover,the proliferation of EJ cells was slowed down,and the proportion of cells at S phase was decreased and that at G2/M phase was blocked after rAAV-VP3 infection as compared with control group (P <0.01 ).Conclusion AAV-mediated VP3 gene transfer may be a new therapeutic technique for the treatment of bladder neoplasms,which may lay a foundation for further studies on anti-tumor effect of bladder cancer in vivo. Key words: VP3 protein; Bladder neoplasm; Gene therapy
Key concepts: Adeno-associated virus, Recombinant DNA, Molecular biology, Biology, Virology, Recombinant virus, Virus, Plasmid